首页/数据集/Clinical and auxological characteristics of groups according to age at initiation of GnRHa therapy.

Clinical and auxological characteristics of groups according to age at initiation of GnRHa therapy.

Figshare2018-08-22 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Clinical_and_auxological_characteristics_of_groups_according_to_age_at_initiation_of_GnRHa_therapy_/6996392 数据链接链接失效反馈

官方服务：

资源简介：

Clinical and auxological characteristics of groups according to age at initiation of GnRHa therapy.

应用场景：

创建时间：

2018-08-22

儿科内分泌治疗

生长激素缺乏症

Baseline demographic and clinical characteristics of children (≥3 and <16 years) with pGHD treated with daily somatropin in Japan.

NIAID Data Ecosystem50

Supplementary Material for: Response to rhGH therapy in short children born at very low birth weight

儿科内分泌治疗

生长激素疗效评估

Introduction: Although the clinical benefits of long-term rhGH therapy have been well demonstrated in children born small for gestational age (SGA), little is known about the outcomes of this therapy

Figshare2024-11-13 更新30

Supplementary Material for: Efficacy and Safety of Once-Weekly Somatrogon Compared With Once-Daily Somatropin (Genotropin®) in Japanese Children With Pediatric Growth Hormone Deficiency: Results From a Randomized Phase 3 Study

儿科内分泌治疗

生长激素治疗效应

Introduction Somatrogon is a long-acting recombinant human growth hormone being developed as a once weekly treatment for children with growth hormone deficiency (GHD). The objective of this Phase 3 st

Figshare2022-04-13 更新10

Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study

儿科内分泌治疗

药物长期安全性

Purpose The aim of this registry study was to analyze the long-term safety and effectiveness of recombinant human growth hormone (rhGH) in South Korean pediatric patients (≥2 years of age) with growth

NIAID Data Ecosystem40

The use of aromatase inhibitors in boys with short stature: what to know before prescribing?

儿科内分泌治疗

药物相互作用

ABSTRACT Aromatase is a cytochrome P450 enzyme (CYP19A1 isoform) able to catalyze the conversion of androgens to estrogens. The aromatase gene mutations highlighted the action of estrogen as one of th

NIAID Data Ecosystem30

Clinical and auxological characteristics of groups according to age at initiation of GnRHa therapy.

资源简介：

相关数据集